周五盘中，医疗设备公司Globus Medical Inc（股票代码：GMED）股价大涨5.07%，引发市场关注。这一显著涨幅主要得益于公司发布的强劲季度财报，超出了分析师的预期。
根据Globus Medical公布的最新财报，截至6月30日的季度中，公司调整后每股收益达到0.86美元，显著高于分析师平均预期的0.76美元。公司营收同比增长18.4%，达到7.4534亿美元，同样超过了分析师7.4181亿美元的预期。此外，公司本季度净收入达到2.0285亿美元，展现了强劲的盈利能力。
值得注意的是，尽管Globus Medical今年以来股价下跌了36.1%，但分析师对公司前景仍保持乐观态度。目前，分析师对该公司股票的平均评级为"买入"，其中9个为"强烈买入"或"买入"，6个为"持有"，没有"卖出"或"强烈卖出"评级。华尔街分析师给出的Globus Medical 12个月目标价中位数为80.00美元，较前一交易日收盘价54.07美元高出约32.4%，显示出投资者对公司未来增长潜力的信心。这些积极因素可能继续支撑Globus Medical的股价表现。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.